Key result
Circulating inflammatory biomarkers and non-invasive imaging techniques may improve cardiovascular risk stratification, although their clinical utility has not yet been firmly established.
Why the study?
Do integrated biomarkers improve long-term risk stratification for cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosis?
Do integrated biomarkers improve long-term risk stratification for cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosis?
While integrated biomarkers and imaging show potential for improving cardiovascular risk stratification, their clinical utility remains to be firmly established.
No takes yet. Share an insight, caveat, or question.
Does not support routine adoption in risk stratification; leaves open incremental value of integrated biomarkers in primary and secondary prevention.
Wolfgang Köenig (2009) conducted a review in Cardiovascular diseases. Biomarkers and non-invasive imaging techniques was evaluated on Cardiovascular events. Circulating inflammatory biomarkers and non-invasive imaging techniques may improve cardiovascular risk stratification, although their clinical utility has not yet been firmly established.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: